Nucleic Acid Amplification Testing (NAT) for detection of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) & Human Immunodeficiency Virus (HIV).
Newborn Screening to detect more than 30 inherited metabolic disorders (IEM).
Next Generation Sequencing for exome and genome, solid tumour analysis and genotyping array.
Skill-based training courses for students and allied health professionals.
Synapse Sdn Bhd is a medical laboratory and healthcare group with strategic focus on development and implementation of reference technologies for healthcare testing.
We provide specialised medical testing services such as Nucleic Acid Amplification Testing (NAT), Newborn Screening and other molecular genetic testing services to healthcare practitioners, hospitals and corporate clients around the region. Our laboratory also carry out research and experimental work to enhance the company's services and enable the commercialization of research and technology for healthcare testing.
Synapse Laboratory partners with market-leaders in medical sciences and facilitate innovative new technologies to offer unique screening and diagnostic solutions.
Synapse Laboratory follows the MS ISO 15189:2014 guidelines and requirements of quality and competence for medical laboratories.
As part of our commitment to provide quality testing, Synapse Laboratory participates in recognised EQA programs.
Synapse Laboratory follows the MS ISO 15189:2014 guidelines and requirements of quality and competence for medical laboratories.
As part of our commitment to provide quality testing, Synapse Laboratory participates in recognised EQA programs.